SE437985B - NEW N-METOXICARBONYL-N? 721-SUBSTITUTED HYDRAZINE USED AS AN INTERMEDIATE FOR THE PREPARATION OF METHYL-3- (2-CHINOXALINYLMETHYL) -CARBAZATE-N? 721, N? 724-DI - Google Patents

NEW N-METOXICARBONYL-N? 721-SUBSTITUTED HYDRAZINE USED AS AN INTERMEDIATE FOR THE PREPARATION OF METHYL-3- (2-CHINOXALINYLMETHYL) -CARBAZATE-N? 721, N? 724-DI

Info

Publication number
SE437985B
SE437985B SE8003393A SE8003393A SE437985B SE 437985 B SE437985 B SE 437985B SE 8003393 A SE8003393 A SE 8003393A SE 8003393 A SE8003393 A SE 8003393A SE 437985 B SE437985 B SE 437985B
Authority
SE
Sweden
Prior art keywords
carbazate
methyl
preparation
methoxycarbonyl
new
Prior art date
Application number
SE8003393A
Other languages
Swedish (sv)
Other versions
SE8003393L (en
Inventor
L J Czuba
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of SE8003393L publication Critical patent/SE8003393L/en
Publication of SE437985B publication Critical patent/SE437985B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/50Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to ring nitrogen atoms
    • C07D241/52Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Description

80033934- 2 för framställning av metyl-3-(2-kinoxalinylmetylen)-karbazat- -Nl,N4-dioxid, som har formeln: O + N , cH=NNHcoocH I N'/ < 3 í:;::]:: fiïlt + o 4 vilket utmärkes därav, att en 2-halometylkinoxalin-Nl,N - -dioxid med formeln: II CH X O4-Z vari X är klor eller brom, bringas att reagera med en till två ekvivalenter av ett alkalimetallkarbonat och en till tvâ ekvivalenter av en hydrazin, som har formeln: R“NHNHCOOCH3“ III vari R" betecknar cF3so2,tcF3cH2so2, cH3so2 eller CH C H S0 , i ett reaktionsinert lösningsmedel vid en tem- 3 6 4 2 0 peratur från 75 till 85 C, varefter det önskade karbazatet med formeln I utvinnes. 80033934-2 for the preparation of methyl 3- (2-quinoxalinylmethylene) -carbazate--N1, N4-dioxide having the formula: O + N, cH = NNHcoocH I N '/ <3 í:; ::] :: ï ïlt + o 4 which is characterized in that a 2-halomethylquinoxaline-N1, N - -dioxide of the formula: II CH X O4-Z wherein X is chlorine or bromine, is reacted with one to two equivalents of an alkali metal carbonate and one more two equivalents of a hydrazine having the formula: R "NHNHCOOCH3" III wherein R "represents cF3so2, tcF3cH2so2, cH3so2 or CH CH SOO, in a reaction-inert solvent at a temperature from 75 to 85 C, after which the desired carbazate of formula I is recovered.

Det ovannämnda förfarandet, vilket innefattar reaktion av en 2-halometylkinoxalin-Nl,N4-dioxid i ett reaktionsinert lös- ningsmedel i närvaro av ett alkalimetallkarbonat, t.ex. vattenfritt kaliumkarbonat, med en alkyl- eller arylsulfonyl- substituerad hydrazin, t.ex. N-metoxikarbonyl-N'-trify1- hydrazin, kan representeras med följande reaktionsschema: âuuaasa-9 3 o cF o + | 3 + N S02 N / \ »Im K2C°3 \ + J/ -____;> // N f NH N + Cflzx | + cn=NNHco2cH3 + o coocu3 o CF SO_K+ I: III I 3 2 Vid en föredragen utföringsform av förfarandet upphettas en 2-halometylkinoxalin~Nl,N4-dioxid, företrädesvis 2-bromo- metylkinoxalinföreningen, till en temperatur av 75-85OC i ett reaktionsinert lösningsmedel såsom acetonitril med en till två ekvivalenter N-metoxikarbonyl-N'-trifylhydrazin i närvaro av en till två ekvivalenter vattenfritt kaliumkarbo- nat, tills reaktionen är väsentligen fullständig (ungefär l-2 timmar). Företrädesvis utföres reaktionen med en ekvi- molär mängd kaliumkarbonat och N-metoxikarbonyl-N'-trifyl- hydrazin.The above process, which comprises reacting a 2-halomethylquinoxaline-N1, N4 dioxide in a reaction inert solvent in the presence of an alkali metal carbonate, e.g. anhydrous potassium carbonate, with an alkyl- or arylsulfonyl-substituted hydrazine, e.g. N-methoxycarbonyl-N'-triphyl-hydrazine, can be represented by the following reaction scheme: âuuaasa-9 3 o cF o + | 3 + N SO 2 N / \ »Im K2C ° 3 \ + J / -____;> // N f NH N + C fl zx | In a preferred embodiment of the process, a 2-halomethylquinoxaline, N4 dioxide, preferably 2-bromomethylquinoxaline compound, is heated to a temperature of 75-85 ° C in a reaction-inert solvent such as acetonitrile with one to two equivalents of N-methoxycarbonyl-N'-triphylhydrazine in the presence of one to two equivalents of anhydrous potassium carbonate, until the reaction is substantially complete (about 1-2 hours). Preferably the reaction is carried out with an equimolar amount of potassium carbonate and N-methoxycarbonyl-N'-triphylhydrazine.

De 2-halometylkinoxalinderivat, som användes vid förfarandet ovan, framställes lättare och mer ekonomiskt än de motsva- rande 2-bis(halogeno)-metylkinoxalinföreningarna, som beskri- ves i den amerikanska patentskriften 3.839.326.The 2-halomethylquinoxaline derivatives used in the above process are prepared more readily and more economically than the corresponding 2-bis (halo) methylquinoxaline compounds described in U.S. Pat. No. 3,839,326.

De 2-halometylkinoxalinintermediat, som användes vid för- farandet ovan, kan framställas enligt de allmänna metoder som beskrives i den amerikanska patentskriften 3.753.987, J. Chem. Soc., 2052 (1956) och Chemistry of Heterocyclic Compounds, 940 (1967). Halogenen kan vara klor eller brom.The 2-halomethylquinoxaline intermediates used in the above process can be prepared according to the general methods described in U.S. Pat. No. 3,753,987, J. Chem. Soc., 2052 (1956) and Chemistry of Heterocyclic Compounds, 940 (1967). The halogen can be chlorine or bromine.

De föredragna intermediaten är 2-bromometylkinoxalinföre- ningarna. Dessa föreningar framställes av 2-metylkinoxalin- -1,4-dioxider enligt de metoder som beskrives i J. Chem. Soc., 322 (1943), de amerikanska patentskrifterna 3.474.097, 3.553.208, 3.660.398 och den brittiska patentskriften 1.215.815.The preferred intermediates are the 2-bromomethylquinoxaline compounds. These compounds are prepared from 2-methylquinoxaline-1,4-dioxides according to the methods described in J. Chem. Soc., 322 (1943), U.S. Pat. Nos. 3,474,097, 3,553,208, 3,660,398 and British Pat. No. 1,215,815.

N-metoxikarbonyl-N'-trifylhydrazin, N-metoxikarbonyl-N'-tre- aoozzsz-9 -4 sylhydrazin, N-metoxikarbonyl-N'~metansulfonylhydrazin och N-metoxikarbonyl-N'-tosylhydrazin kan framställas enligt det allmänna förfarande som beskrives i J. Org. Chem., gg, 3450 (1975). Exempelvis kan N-metoxikarbonyl-N'-trifylhydrazin framställas på så sätt, att man sätter en lösning av triflikSyrfi~ anhydrid i metylenklorid droppvis till en metylenkloridlös- ning innehållande en ekvimolär mängd metylkarbazat och ett ringa molärt överskott av trietylamin vid -78°C. Den er- hållna blandningen får anta rumstemperatur och omröres i ungefär 16 timmar. Blandningen koncentreras under vakuum vid rumstemperatur och återstoden extraheras därefter med ett flertal portioner eter. Eterextraktet koncentreras under vakuum vid rumstemperatur till en vaxartad fast substans, som användes direkt vid efterföljande reaktion utan ytter- ligare rening. Alternativt ger utelämnande av trietylamin och användning av två ekvivalenter metylkarbazat den kris- tallina produkten.N-methoxycarbonyl-N'-triphylhydrazine, N-methoxycarbonyl-N'-triazol-2-sylhydrazine, N-methoxycarbonyl-N'-methanesulfonylhydrazine and N-methoxycarbonyl-N'-tosylhydrazine can be prepared according to the general procedure described and J. Org. Chem., Vol., 3450 (1975). For example, N-methoxycarbonyl-N'-triphylhydrazine can be prepared by adding a solution of triflic acid anhydride in methylene chloride dropwise to a methylene chloride solution containing an equimolar amount of methyl carbazate and a slight molar excess of triethylamine. The resulting mixture is allowed to warm to room temperature and stirred for about 16 hours. The mixture is concentrated in vacuo at room temperature and the residue is then extracted with several portions of ether. The ether extract is concentrated in vacuo at room temperature to a waxy solid, which is used directly in the subsequent reaction without further purification. Alternatively, the omission of triethylamine and the use of two equivalents of methyl carbazate give the crystalline product.

N-metoxikarbonyl-N'-trifylhydrazin och N-metoxikarbonyl-N'- -tresylhydrazin är nya föreningar och följaktligen åstad- kommes enligt uppfinningen en ny N-metoxikarbonyl-N'-substi- tuerad hydrazin, som är användbar såsom ett intermediat vid framställning av föreningen med formeln I ovan, vilken ut- märkes därav, att den har formeln: R"NHNHCOOCH III 3 vari R" är CF3S02.N-methoxycarbonyl-N'-triphylhydrazine and N-methoxycarbonyl-N'-tresylhydrazine are novel compounds and consequently the invention provides a novel N-methoxycarbonyl-N'-substituted hydrazine which is useful as an intermediate in the preparation of of the compound of formula I above, which is characterized in that it has the formula: R "NHNHCOOCH III 3 wherein R" is CF 3 SO 2.

Följande exempel belyser framställning av det nya inter- mediatet enligt uppfinningen.The following examples illustrate the preparation of the new intermediate according to the invention.

Exempel l.Example 1

N-metoxikarbonyl-N'-trifylhydrazin. ,4 mmol trifliksyraanhydrid i 40 ml metylenklorid sattes droppvis till en lösning av 35,5 mmol metylkarbazat och 38,9 mmol trietylamin i 200 ml metylenklorid vid -78°C under omröring. Den resulterande blandningen tilläts anta rums- temperatur under vakuum och återstoden extraherades med aoozsez-9 3 x 100 ml återflödesupphettad eter. Det kombinerade eter- extraktet koncentrerades under vakuum vid rumstemperatur för bildning av en vaxartad, fast substans (5,26 g, ungefär 67 %).N-methoxycarbonyl-N'-triphylhydrazine. 4 mmol of triflic acid anhydride in 40 ml of methylene chloride were added dropwise to a solution of 35.5 mmol of methyl carbazate and 38.9 mmol of triethylamine in 200 ml of methylene chloride at -78 ° C with stirring. The resulting mixture was allowed to warm to room temperature under vacuum and the residue was extracted with aoozsez-9 3 x 100 ml refluxed ether. The combined ether extract was concentrated in vacuo at room temperature to give a waxy solid (5.26 g, about 67%).

NMR-spektret för den orena produkten bekräftade den förväntade produkten, förorenad med trietylaminsaltet av trifliksyra.The NMR spectrum of the crude product confirmed the expected product, contaminated with the triethylamine salt of triflic acid.

Det orena materialet användes direkt utan ytterligare rening i efterföljande reaktioner. 336 mmol metylkarbazat sattes under 20 minuters omröring till en lösning av 178 mmol trifliksyraanhydrid i 2000 ml metylen- klorid under kväveatmosfär vid ~78°C. Den erhållna lösningen tilläts anta rumstemperatur och omrördes 20 timmar. Den bildade, tjocka, vita suspensionen koncentrerades under vakuum vid rumstemperatur för bildning av en vit, fast substans. Detta material triturerades med 450 ml dietyleter och tillvaratogs för bildning av metylkarbazatsaltet av tri- fliksyra. Dietyleterfiltratet koncentrerades under vakuum vid rumstemperatur för bildning av en vit, fast substans, som triturerades med hexan och tillvaratogs, tvättades med hexan och torkades för bildning av produkten såsom en vit kristallin substans (utbyte 84 %) med smältpunkten 107-l09°C.The crude material was used directly without further purification in subsequent reactions. 336 mmol of methyl carbazate was added with stirring for 20 minutes to a solution of 178 mmol of triflic acid anhydride in 2000 ml of methylene chloride under a nitrogen atmosphere at ~ 78 ° C. The resulting solution was allowed to warm to room temperature and stirred for 20 hours. The resulting thick white suspension was concentrated in vacuo at room temperature to give a white solid. This material was triturated with 450 ml of diethyl ether and collected to give the methyl carbazate salt of triflic acid. The diethyl ether filtrate was concentrated in vacuo at room temperature to give a white solid, which was triturated with hexane and collected, washed with hexane and dried to give the product as a white crystalline substance (yield 84%), m.p. 107 DEG-109 DEG.

C3H5O4N2F3S: Beräknat: C 16,21 H 2,25 N 12,61 % Funnet : C l6,24 H 2,20 N 12,68 %. :w-.fl-w-»p-o ~ _ _ _, U-...mw-H-e-w -~ . ._.,._ _C 3 H 5 O 4 N 2 F 3 S: Calculated: C 16.21 H 2.25 N 12.61% Found: C 16.24 H 2.20 N 12.68%. : w-. fl- w- »p-o ~ _ _ _, U -... mw-H-e-w - ~. ._., ._ _

Claims (1)

1. 8003393-9 PATENTKRAV Ny N-metoxikarbonyl-N'-substituerad hydrazin, som är användbar såsom ett intermediat vid framställning av metyl- -3-(2-kinoxalinylmetylen)~karbazat-Nl,N4-dioxid, som har formeln: O + N \ _ I /, H-NNHCOOCH3 N + O ...I k ä n n e t e c k n a d därav, att den har formeln: R"NHNHcoocH3 III vari R" är CF3S02-A new N-methoxycarbonyl-N'-substituted hydrazine, which is useful as an intermediate in the preparation of methyl -3- (2-quinoxalinylmethylene) -carbazate-N1, N4-dioxide, having the formula: H-NNHCOOCH3 N + O ... It is characterized in that it has the formula: R "NHNHCOOCH3 III wherein R" is CF3SO2-
SE8003393A 1976-06-15 1980-05-06 NEW N-METOXICARBONYL-N? 721-SUBSTITUTED HYDRAZINE USED AS AN INTERMEDIATE FOR THE PREPARATION OF METHYL-3- (2-CHINOXALINYLMETHYL) -CARBAZATE-N? 721, N? 724-DI SE437985B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69626376A 1976-06-15 1976-06-15

Publications (2)

Publication Number Publication Date
SE8003393L SE8003393L (en) 1980-05-06
SE437985B true SE437985B (en) 1985-03-25

Family

ID=24796354

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7705744A SE428925B (en) 1976-06-15 1977-05-16 IMPROVED PROCEDURE FOR THE PREPARATION OF METHYL-3- (2-KINOXALINYLMETHYIN) -CARBAZATE-N? 721, N? 724-DIOXIDE
SE8003393A SE437985B (en) 1976-06-15 1980-05-06 NEW N-METOXICARBONYL-N? 721-SUBSTITUTED HYDRAZINE USED AS AN INTERMEDIATE FOR THE PREPARATION OF METHYL-3- (2-CHINOXALINYLMETHYL) -CARBAZATE-N? 721, N? 724-DI

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE7705744A SE428925B (en) 1976-06-15 1977-05-16 IMPROVED PROCEDURE FOR THE PREPARATION OF METHYL-3- (2-KINOXALINYLMETHYIN) -CARBAZATE-N? 721, N? 724-DIOXIDE

Country Status (31)

Country Link
JP (2) JPS52153986A (en)
AR (1) AR221207A1 (en)
AT (1) AT357562B (en)
BG (1) BG35595A3 (en)
CA (1) CA1087616A (en)
CH (1) CH620911A5 (en)
CS (1) CS200218B2 (en)
DD (2) DD135080A5 (en)
DE (1) DE2725023A1 (en)
DK (1) DK142497B (en)
ES (2) ES459745A1 (en)
FI (1) FI771742A (en)
GB (3) GB1591872A (en)
GR (1) GR72289B (en)
HK (3) HK2083A (en)
IE (1) IE44684B1 (en)
IL (1) IL52166A0 (en)
IT (1) IT1078874B (en)
LU (1) LU77474A1 (en)
MY (2) MY8300230A (en)
NL (2) NL166685C (en)
NO (2) NO146864C (en)
NZ (1) NZ184167A (en)
PH (2) PH14866A (en)
PL (1) PL105555B1 (en)
PT (1) PT66618B (en)
SE (2) SE428925B (en)
SG (1) SG49282G (en)
SU (1) SU657746A3 (en)
YU (1) YU39492B (en)
ZA (1) ZA772979B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60164410A (en) * 1984-02-08 1985-08-27 株式会社石井製作所 Threshing and sorting apparatus

Also Published As

Publication number Publication date
IT1078874B (en) 1985-05-08
JPS5725542B2 (en) 1982-05-29
BG35595A3 (en) 1984-05-15
DK240777A (en) 1977-12-16
JPS5589256A (en) 1980-07-05
ATA387077A (en) 1979-12-15
CA1087616A (en) 1980-10-14
SG49282G (en) 1984-02-17
PH14481A (en) 1981-08-07
HK2083A (en) 1983-01-13
NO147422C (en) 1983-04-06
SU657746A3 (en) 1979-04-15
IE44684B1 (en) 1982-02-24
ZA772979B (en) 1978-04-26
DK142497B (en) 1980-11-10
GB1591874A (en) 1981-07-01
NZ184167A (en) 1981-02-11
NL166685C (en) 1981-09-15
CH620911A5 (en) 1980-12-31
GR72289B (en) 1983-10-17
HK1883A (en) 1983-01-13
PT66618A (en) 1977-06-01
AR221207A1 (en) 1981-01-15
NL166685B (en) 1981-04-15
PT66618B (en) 1978-10-27
NO813221L (en) 1977-12-16
SE7705744L (en) 1977-12-16
SE428925B (en) 1983-08-01
NO147422B (en) 1982-12-27
DD135080A5 (en) 1979-04-11
JPS5652019B2 (en) 1981-12-09
HK1983A (en) 1983-01-13
ES459745A1 (en) 1978-04-01
NO146864B (en) 1982-09-13
PH14866A (en) 1982-01-08
IL52166A0 (en) 1977-07-31
AT357562B (en) 1980-07-25
PL105555B1 (en) 1979-10-31
DE2725023A1 (en) 1977-12-22
YU132777A (en) 1982-08-31
DK142497C (en) 1981-03-23
CS200218B2 (en) 1980-08-29
IE44684L (en) 1977-12-15
SE8003393L (en) 1980-05-06
MY8300229A (en) 1983-12-31
LU77474A1 (en) 1978-01-26
GB1591873A (en) 1981-07-01
ES459750A1 (en) 1978-04-01
YU39492B (en) 1984-12-31
DD131371A5 (en) 1978-06-21
FI771742A (en) 1977-12-16
GB1591872A (en) 1981-07-01
NL8006697A (en) 1981-03-31
JPS52153986A (en) 1977-12-21
NO771903L (en) 1977-12-16
MY8300230A (en) 1983-12-31
PL198873A1 (en) 1978-04-24
NO146864C (en) 1982-12-22
NL7705938A (en) 1977-12-19

Similar Documents

Publication Publication Date Title
US20130137881A1 (en) Method for producing a methylene disulfonate compound
SE437985B (en) NEW N-METOXICARBONYL-N? 721-SUBSTITUTED HYDRAZINE USED AS AN INTERMEDIATE FOR THE PREPARATION OF METHYL-3- (2-CHINOXALINYLMETHYL) -CARBAZATE-N? 721, N? 724-DI
JPH0570437A (en) Process for producing 1-carbamoylpyrazol
JPH07116126B2 (en) 2,3-diaminoacrylonitrile derivative
JPS6087251A (en) Manufacture of substituted benzamide derivative
US3118903A (en) 2-oxo-1, 2, 3, 5-oxathiadiazoles and methods for preparing the same
RU2036196C1 (en) Method of synthesis of (±) -6- cyano- 3,4- dihydro -2,2-dimethyl -trans -4- (2-hydroxo -1-pyrrolidinyl) -2h-1- benzopyran -3-ol
EP0070467B1 (en) Process for synthesising n-isopropyl-n&#39;-o-carbomethoxyphenylsulphamide
US4236017A (en) Process for synthesizing 2-substituted semicarbazones and carbalkoxy hydrazones
EP0163926B1 (en) Process for the preparation of acemetacin
SU415876A3 (en) METHOD FOR PRODUCING DERIVATIVES OF BENZIMIDAZOLE
JP2561480B2 (en) Process for producing 4,6-dialkoxy-2-alkylthiopyrimidines
EP0853077B1 (en) Process for producing alkyl 3-amino-4-substituted benzoates
EP0034421B1 (en) N-phenyl-n&#39;-cyano-0-phenylisoureas and process for their preparation
EP0317207B1 (en) Production of 2,3&#39;-anhydro-2&#39;deoxyuridine derivatives
KR820000786B1 (en) Process for preparing uracil derivatives
US4173581A (en) Process for the preparation of alkylthiosemicarbazides
US4459415A (en) Process for the preparation of 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-3-indoleacetoxyacetic acid
EP0274353B1 (en) Process for the preparation of benzoin sulfonates
JPH0560832B2 (en)
US4452992A (en) Process for the production of ethoxycarbonylmethyl 5-(2,6-dichloro-4-trifluoro-methylphenoxy)-2-nitro-α-phenoxy-propionate
SU882187A1 (en) 1,1-dioxo-3-hydroxythiolanyl-4-isothiouronic salts as initial substance for synthesis of 3,4-thriiranothiolan-1,1-dioxide
SU1299507A3 (en) Method for producing derivatives of fluormethylquinoline
US4117043A (en) Process for the manufacture of n-(beta-diorganodithiophosphorylethyl) aryl and alkyl sulfonamides
SU788644A1 (en) PYRROLIDONE-2NITROBENZENESULPHATE AND ITS CHLORANGIDRID AS INTERMEDIATE PRODUCTS FOR FUNGICIDES SYNTHESIS

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8003393-9

Effective date: 19941210

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8003393-9

Format of ref document f/p: F